Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 3

Diyabetik nöropatili hastalarda serum asimetrik dimetilarginin ve nitrik oksit düzeyleri

Serum asymmetric dimethylarginine and nitric oxide levels in patients with diabetic neuropathy

Pages
183–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion: Changes in NO and ADMA levels in the blood of diabetic neuropathy patients may indicate oxidative stress and endothelial dysfunction in the pathogenesis of diabetic neuropathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Asymmetric dimethylarginine (ADMA) is a novel marker of endothelial dysfunction.
📊
Key Findings & Data:In this case control study, we aimed to evaluate the relationship between serum NO and ADMA levels among diabetic neuropathy cases Methods: 48 patients with diabetic neuropathy and 34 healthy subjects were included in the study.
💡
Conclusion & Impact:Discussion: Changes in NO and ADMA levels in the blood of diabetic neuropathy patients may indicate oxidative stress and endothelial dysfunction in the pathogenesis of diabetic neuropathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Asymmetric dimethylarginine (ADMA) is a novel marker of endothelial dysfunction. ADMA is an endothelial nitric oxide synthase inhibitor. Due to scarcity of studies on the role of ADMA in pathogenesis of diabetic neuropathy, it remains to be determined whether blood ADMA and nitric oxide (NO) levels are associated with diabetic neuropathy. In this case control study, we aimed to evaluate the relationship between serum NO and ADMA levels among diabetic neuropathy cases Methods: 48 patients with diabetic neuropathy and 34 healthy subjects were included in the study. All type 2 diabetic patients underwent electrophysiological and neurological examination. NO levels were determined using the Griess method. Serum ADMA levels were determined by using the ELISA method. Results: The serum ADMA levels in diabetic neuropathy patients were found to be statistically significantly lower than those of the control group (p=0.005). However, a statistically significant increase was observed in serum NO levels in patients with diabetic neuropathy compared with those in the control group (p = 0.009). A negative correlation was found between NO levels and ADMA levels (p=0.041, r=-0.23). Discussion: Changes in NO and ADMA levels in the blood of diabetic neuropathy patients may indicate oxidative stress and endothelial dysfunction in the pathogenesis of diabetic neuropathy.

Özet

Amaç: Asimetrik dimetil arginin (ADMA) endotel fonksiyon bozukluğunun yeni bir belirtecidir. ADMA endotelyal nitric oksit (NO) sentaz inhibitörüdür. Diyabetik nöropatinin patogenezinde ADMA’nın rolü ile ilgili çok az çalışma vardır. Bu yüzden diabetik nöropatinin serum ADMA ve NO düzeyleri arasında ilişki olup olmadığı belirlenmemiştir. Bu vaka kontrol çalışmamızda diyabetik nöropatili hastalarda serum NO ve ADMA seviyeleri arasında ilişkiyi araştırmayı amaçladık. Yöntem: Diyabetik nöropatili 48 hasta ve 34 sağlıklı kişi çalışmaya alındı. Tüm tip 2 diyabetik hastalara elektrofizyolojik inceleme ve nörolojik muayene yapıldı. NO seviyesi Griess metoduyla belirlendi. Serum ADMA düzeyi ELİSA metoduyla ölçüldü. Bulgular: Serum ADMA düzeyi diyabetik nöropatili hastalarda kontrol grubuna göre istatistiksel olarak anlamlı düzeyde azalmış bulundu (p=0,005). Bununla birlikte diyabetik nöropatili hastalarda NO düzeyinde kontrol grubuna göre anlamlı düzeyde artış saptandı (p= 0,009). Bu çalışmada NO düzeyleri ile ADMA düzeyleri arasında negative bir korelasyon bulundu (p=0,041, r=-0,23). Sonuç: Sonuç olarak diyabetik nöropatili hastaların kanında NO ve ADMA düzeyinde değişiklikler olması diyabetik nöropatinin patogenezinde oksidatif stresi ve endotel fonksiyon bozukluğunu işaret edebilir.

🔖

Cite This Article

TAMAM, Y., UZAR, E., EVLİYAOĞLU, O., TAY, A., KILINÇ, F., ÇEVİK, M. U. (2012). Diyabetik nöropatili hastalarda serum asimetrik dimetilarginin ve nitrik oksit düzeyleri. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 3, 183–187. https://ajindex.com/articles/292666

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Norlinah MI, Hamizah R, Md Isa SH, Wan Nazaimoon WM, Khalid BA. The effects of short-term, rapid glycemic control on the peroneal nerve function and serum VCAM-1 and AGE in type 2 diabetic patients in Malaysia. Indian J Med Sci 2009
  2. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007
  3. Jeong JO, Kim MO, Kim H, Lee MY, Kim SW, Ii M, Lee JU, Lee J, Choi YJ, Cho HJ, Lee N, Silver M, Wecker A, Kim DW, Yoon YS. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 2009
  4. Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA. The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 2010
  5. Abhary S, Kasmeridis N, Burdon KP, Kuot A, Whiting MJ, Yew WP, Petrovsky N, Craig JE. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. Diabetes Care 2009
  6. Deguchi T, Hashiguchi T, Horinouchi S, Uto T, Oku H, Kimura K, Makisumi K, Arimura K. Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabet Med 2009
  7. Yokoyama H, Yokota Y, Tada J, Kanno S. Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes. Diabet Med 2007
  8. Vivekanadan-Giri A, Wang JH, Byun J, Pennathur S. Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage. Rev Endocr Metab Disord 2008
  9. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000
  10. Uzar E, Evliyaoglu O, Toprak G, Acar A, Yucel Y, Calisir T, Cevik MU, Tasdemir N. Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine. J Headache Pain 2011
  11. Hanai K, Babazono T, Nyumura I, Toya K, Tanaka N, Tanaka M, Ishii A, Iwamoto Y. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes. Nephrol Dial Transplant 2009
  12. Yaşar H, Senol MG, Kend